2023-2029 Global Endothelin Antagonists Therapeutics Industry Research & Trends Analysis Report
2023-2029 Global Endothelin Antagonists Therapeutics Industry Research & Trends Analysis Report
The Endothelin Antagonists Therapeutics study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Study, the global market for Endothelin Antagonists Therapeutics should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Endothelin Antagonists Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Endothelin Antagonists Therapeutics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Cardiovascular Diseases has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Endothelin Antagonists Therapeutics include Gilead Sciences, Inc, Sun Pharmaceutical Industries Ltd, Lupin, Zydus Group, Endo International plc, Mylan NV, Teva Pharmaceutical Industries Ltd, Sigmapharm Laboratories , LLC and Alembic Pharmaceuticals Limited, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Endothelin are the type of therapeutics that inhibits the action of endothelin and is thus effective for treating pulmonary arterial hypertension. This receptor, which plays a major role in regulating vascular tone, is found between the lumen and underlying media of the pulmonary vasculature. For patients suffering from the pulmonary hypertension, the body secrete high amount of endothelin that causes the blood vessels to be constricted and increase in the BP in the pulmonary arteries.
This report aims to provide a comprehensive study of the global market for Endothelin Antagonists Therapeutics. Report Highlights:
(1) Global Endothelin Antagonists Therapeutics market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Endothelin Antagonists Therapeutics market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Endothelin Antagonists Therapeutics market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Endothelin Antagonists Therapeutics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Endothelin Antagonists Therapeutics segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Endothelin Antagonists Therapeutics, capacity, production and trends.
(7) Endothelin Antagonists Therapeutics industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral
Parenteral
Market segment by application, can be divided into
Cardiovascular Diseases
Scleroderma
Other
Market segment by players, this report covers
Gilead Sciences, Inc
Sun Pharmaceutical Industries Ltd
Lupin
Zydus Group
Endo International plc
Mylan NV
Teva Pharmaceutical Industries Ltd
Sigmapharm Laboratories , LLC
Alembic Pharmaceuticals Limited
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
AstraZeneca
Johnsons & Johnsons Private limited
GSK Plc
1 Market Overview
1.1 Endothelin Antagonists Therapeutics Definition
1.2 Global Endothelin Antagonists Therapeutics Market Size and Forecast
1.2.1 By Revenue, Global Endothelin Antagonists Therapeutics Market Size, 2018-2029
1.2.2 By Sales Volume, Global Endothelin Antagonists Therapeutics Market Size, 2018-2029
1.2.3 Global Endothelin Antagonists Therapeutics Price Trend, 2018-2029
1.3 China Endothelin Antagonists Therapeutics Market Size and Forecast
1.3.1 By Revenue, China Endothelin Antagonists Therapeutics Market Size, 2018-2029
1.3.2 By Sales Volume, China Endothelin Antagonists Therapeutics Market Size, 2018-2029
1.3.3 China Endothelin Antagonists Therapeutics Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Endothelin Antagonists Therapeutics Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Endothelin Antagonists Therapeutics Share in Global Market, 2018-2029
1.4.3 Endothelin Antagonists Therapeutics Market Size: China VS Global, 2018-2029
1.5 Endothelin Antagonists Therapeutics Market Dynamics
1.5.1 Endothelin Antagonists Therapeutics Market Drivers
1.5.2 Endothelin Antagonists Therapeutics Market Restraints
1.5.3 Endothelin Antagonists Therapeutics Industry Trends
1.5.4 Endothelin Antagonists Therapeutics Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Endothelin Antagonists Therapeutics Revenue by Company, 2018-2023
2.2 Global Endothelin Antagonists Therapeutics Sales Volume by Company, 2018-2023
2.3 Global Endothelin Antagonists Therapeutics Price by Company, 2018-2023
2.4 Global Endothelin Antagonists Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Endothelin Antagonists Therapeutics Concentration Ratio
2.6 Global Endothelin Antagonists Therapeutics Mergers & Acquisitions, Expansion Plans
2.7 Global Endothelin Antagonists Therapeutics Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Endothelin Antagonists Therapeutics Revenue by Company, 2018-2023
3.2 China Endothelin Antagonists Therapeutics Sales Volume by Company, 2018-2023
3.3 China Endothelin Antagonists Therapeutics Endothelin Antagonists Therapeutics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Endothelin Antagonists Therapeutics Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Endothelin Antagonists Therapeutics Domestic VS Export
3.6 China Market, Endothelin Antagonists Therapeutics Import & Export
3.6.1 China Market, Endothelin Antagonists Therapeutics Import & Export, 2018-2029
3.6.2 China Endothelin Antagonists Therapeutics Import & Export Trends
3.6.3 Main Sources of China Endothelin Antagonists Therapeutics Import
3.6.4 Export Destination of China Endothelin Antagonists Therapeutics
4 Endothelin Antagonists Therapeutics Production by Region
4.1 Global Endothelin Antagonists Therapeutics Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Endothelin Antagonists Therapeutics Manufacturers
4.3 Global Major Manufacturers, Endothelin Antagonists Therapeutics Capacity Expansion and Future Plans
4.4 Global Endothelin Antagonists Therapeutics Capacity by Region
4.5 Global Endothelin Antagonists Therapeutics Production by Region
4.5.1 Global Endothelin Antagonists Therapeutics Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Endothelin Antagonists Therapeutics Production by Region, 2018-2023
4.5.3 Global Endothelin Antagonists Therapeutics Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Endothelin Antagonists Therapeutics Industry Chain
5.2 Endothelin Antagonists Therapeutics Upstream Analysis
5.2.1 Endothelin Antagonists Therapeutics Core Raw Materials
5.2.2 Main Manufacturers of Endothelin Antagonists Therapeutics Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Endothelin Antagonists Therapeutics Production Mode
5.6 Endothelin Antagonists Therapeutics Procurement Model
5.7 Endothelin Antagonists Therapeutics Industry Sales Model and Sales Channels
5.7.1 Endothelin Antagonists Therapeutics Sales Model
5.7.2 Endothelin Antagonists Therapeutics Typical Distributors
6 Sights by Type
6.1 Endothelin Antagonists Therapeutics Classification
6.1.1 Oral
6.1.2 Parenteral
6.2 By Type, Global Endothelin Antagonists Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029
6.4 By Type, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029
6.5 By Type, Global Endothelin Antagonists Therapeutics Price, 2018-2029
7 Sights by Application
7.1 Endothelin Antagonists Therapeutics Segment by Application
7.1.1 Cardiovascular Diseases
7.1.2 Scleroderma
7.1.3 Other
7.2 By Application, Global Endothelin Antagonists Therapeutics Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029
7.4 By Application, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029
7.5 By Application, Global Endothelin Antagonists Therapeutics Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Endothelin Antagonists Therapeutics Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029
8.3 By Region, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Endothelin Antagonists Therapeutics Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Endothelin Antagonists Therapeutics Market Size Market Share
8.5 Europe
8.5.1 Europe Endothelin Antagonists Therapeutics Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Endothelin Antagonists Therapeutics Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Endothelin Antagonists Therapeutics Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Endothelin Antagonists Therapeutics Market Size Market Share
8.7 South America
8.7.1 South America Endothelin Antagonists Therapeutics Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Endothelin Antagonists Therapeutics Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Endothelin Antagonists Therapeutics Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029
9.3 By Country, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.4.2 By Company, U.S. Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.5.2 By Company, Europe Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.5.3 By Type, Europe Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.6.2 By Company, China Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.6.3 By Type, China Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.7.2 By Company, Japan Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.7.3 By Type, Japan Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.8.2 By Company, South Korea Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.10.2 By Company, India Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.10.3 By Type, India Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Endothelin Antagonists Therapeutics Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Endothelin Antagonists Therapeutics Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Endothelin Antagonists Therapeutics Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Gilead Sciences, Inc
10.1.1 Gilead Sciences, Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Models, Specifications and Application
10.1.3 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Gilead Sciences, Inc Company Profile and Main Business
10.1.5 Gilead Sciences, Inc Recent Developments
10.2 Sun Pharmaceutical Industries Ltd
10.2.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Models, Specifications and Application
10.2.3 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.2.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.3 Lupin
10.3.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.3.2 Lupin Endothelin Antagonists Therapeutics Models, Specifications and Application
10.3.3 Lupin Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Lupin Company Profile and Main Business
10.3.5 Lupin Recent Developments
10.4 Zydus Group
10.4.1 Zydus Group Company Information, Head Office, Market Area and Industry Position
10.4.2 Zydus Group Endothelin Antagonists Therapeutics Models, Specifications and Application
10.4.3 Zydus Group Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Zydus Group Company Profile and Main Business
10.4.5 Zydus Group Recent Developments
10.5 Endo International plc
10.5.1 Endo International plc Company Information, Head Office, Market Area and Industry Position
10.5.2 Endo International plc Endothelin Antagonists Therapeutics Models, Specifications and Application
10.5.3 Endo International plc Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Endo International plc Company Profile and Main Business
10.5.5 Endo International plc Recent Developments
10.6 Mylan NV
10.6.1 Mylan NV Company Information, Head Office, Market Area and Industry Position
10.6.2 Mylan NV Endothelin Antagonists Therapeutics Models, Specifications and Application
10.6.3 Mylan NV Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Mylan NV Company Profile and Main Business
10.6.5 Mylan NV Recent Developments
10.7 Teva Pharmaceutical Industries Ltd
10.7.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.7.2 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Models, Specifications and Application
10.7.3 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.8 Sigmapharm Laboratories , LLC
10.8.1 Sigmapharm Laboratories , LLC Company Information, Head Office, Market Area and Industry Position
10.8.2 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Models, Specifications and Application
10.8.3 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Sigmapharm Laboratories , LLC Company Profile and Main Business
10.8.5 Sigmapharm Laboratories , LLC Recent Developments
10.9 Alembic Pharmaceuticals Limited
10.9.1 Alembic Pharmaceuticals Limited Company Information, Head Office, Market Area and Industry Position
10.9.2 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Models, Specifications and Application
10.9.3 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Alembic Pharmaceuticals Limited Company Profile and Main Business
10.9.5 Alembic Pharmaceuticals Limited Recent Developments
10.10 Hikma Pharmaceuticals PLC
10.10.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
10.10.2 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Models, Specifications and Application
10.10.3 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.10.5 Hikma Pharmaceuticals PLC Recent Developments
10.11 Amneal Pharmaceuticals LLC
10.11.1 Amneal Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position
10.11.2 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Models, Specifications and Application
10.11.3 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Amneal Pharmaceuticals LLC Company Profile and Main Business
10.11.5 Amneal Pharmaceuticals LLC Recent Developments
10.12 AstraZeneca
10.12.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.12.2 AstraZeneca Endothelin Antagonists Therapeutics Models, Specifications and Application
10.12.3 AstraZeneca Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 AstraZeneca Company Profile and Main Business
10.12.5 AstraZeneca Recent Developments
10.13 Johnsons & Johnsons Private limited
10.13.1 Johnsons & Johnsons Private limited Company Information, Head Office, Market Area and Industry Position
10.13.2 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Models, Specifications and Application
10.13.3 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Johnsons & Johnsons Private limited Company Profile and Main Business
10.13.5 Johnsons & Johnsons Private limited Recent Developments
10.14 GSK Plc
10.14.1 GSK Plc Company Information, Head Office, Market Area and Industry Position
10.14.2 GSK Plc Endothelin Antagonists Therapeutics Models, Specifications and Application
10.14.3 GSK Plc Endothelin Antagonists Therapeutics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 GSK Plc Company Profile and Main Business
10.14.5 GSK Plc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Endothelin Antagonists Therapeutics Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Endothelin Antagonists Therapeutics Market Restraints
Table 3. Endothelin Antagonists Therapeutics Market Trends
Table 4. Endothelin Antagonists Therapeutics Industry Policy
Table 5. Global Endothelin Antagonists Therapeutics Revenue by Company, 2018-2023, US$ million
Table 6. Global Endothelin Antagonists Therapeutics Revenue Market Share by Company, 2018-2023
Table 7. Global Endothelin Antagonists Therapeutics Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Endothelin Antagonists Therapeutics Sales Volume Market Share by Company, 2018-2023
Table 9. Global Endothelin Antagonists Therapeutics Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Endothelin Antagonists Therapeutics Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Endothelin Antagonists Therapeutics Mergers & Acquisitions, Expansion Plans
Table 12. Global Endothelin Antagonists Therapeutics Manufacturers Product Type
Table 13. China Endothelin Antagonists Therapeutics Revenue by Company, 2018-2023, US$ million
Table 14. China Endothelin Antagonists Therapeutics Revenue Market Share by Company, 2018-2023
Table 15. China Endothelin Antagonists Therapeutics Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Endothelin Antagonists Therapeutics Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Endothelin Antagonists Therapeutics Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Endothelin Antagonists Therapeutics Import & Export Trends
Table 19. Main Sources of China Endothelin Antagonists Therapeutics Import
Table 20. Export Destination of China Endothelin Antagonists Therapeutics
Table 21. Global Headquarters and Manufacturing Base of Endothelin Antagonists Therapeutics Manufacturers
Table 22. Global Major Manufacturers, Endothelin Antagonists Therapeutics Capacity Expansion and Future Plans
Table 23. Global Endothelin Antagonists Therapeutics Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Endothelin Antagonists Therapeutics Production by Region, 2018-2023, (K Units)
Table 25. Global Endothelin Antagonists Therapeutics Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Endothelin Antagonists Therapeutics Upstream (Raw Materials)
Table 27. Global Endothelin Antagonists Therapeutics Typical Customers
Table 28. Endothelin Antagonists Therapeutics Typical Distributors
Table 29. By Type, Global Endothelin Antagonists Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Endothelin Antagonists Therapeutics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Endothelin Antagonists Therapeutics Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Endothelin Antagonists Therapeutics Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Endothelin Antagonists Therapeutics Revenue Market Share, 2018-2029
Table 37. By Country, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Endothelin Antagonists Therapeutics Sales Volume Market Share, 2018-2029
Table 39. Gilead Sciences, Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 41. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Gilead Sciences, Inc Company Profile and Main Business
Table 43. Gilead Sciences, Inc Recent Developments
Table 44. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 46. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 48. Sun Pharmaceutical Industries Ltd Recent Developments
Table 49. Lupin Company Information, Head Office, Market Area and Industry Position
Table 50. Lupin Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 51. Lupin Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Lupin Company Profile and Main Business
Table 53. Lupin Recent Developments
Table 54. Zydus Group Company Information, Head Office, Market Area and Industry Position
Table 55. Zydus Group Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 56. Zydus Group Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Zydus Group Company Profile and Main Business
Table 58. Zydus Group Recent Developments
Table 59. Endo International plc Company Information, Head Office, Market Area and Industry Position
Table 60. Endo International plc Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 61. Endo International plc Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Endo International plc Company Profile and Main Business
Table 63. Endo International plc Recent Developments
Table 64. Mylan NV Company Information, Head Office, Market Area and Industry Position
Table 65. Mylan NV Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 66. Mylan NV Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Mylan NV Company Profile and Main Business
Table 68. Mylan NV Recent Developments
Table 69. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 70. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 71. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 73. Teva Pharmaceutical Industries Ltd Recent Developments
Table 74. Sigmapharm Laboratories , LLC Company Information, Head Office, Market Area and Industry Position
Table 75. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 76. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Sigmapharm Laboratories , LLC Company Profile and Main Business
Table 78. Sigmapharm Laboratories , LLC Recent Developments
Table 79. Alembic Pharmaceuticals Limited Company Information, Head Office, Market Area and Industry Position
Table 80. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 81. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Alembic Pharmaceuticals Limited Company Profile and Main Business
Table 83. Alembic Pharmaceuticals Limited Recent Developments
Table 84. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
Table 85. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 86. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 88. Hikma Pharmaceuticals PLC Recent Developments
Table 89. Amneal Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position
Table 90. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 91. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Amneal Pharmaceuticals LLC Company Profile and Main Business
Table 93. Amneal Pharmaceuticals LLC Recent Developments
Table 94. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 95. AstraZeneca Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 96. AstraZeneca Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. AstraZeneca Company Profile and Main Business
Table 98. AstraZeneca Recent Developments
Table 99. Johnsons & Johnsons Private limited Company Information, Head Office, Market Area and Industry Position
Table 100. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 101. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Johnsons & Johnsons Private limited Company Profile and Main Business
Table 103. Johnsons & Johnsons Private limited Recent Developments
Table 104. GSK Plc Company Information, Head Office, Market Area and Industry Position
Table 105. GSK Plc Endothelin Antagonists Therapeutics Models, Specifications and Application
Table 106. GSK Plc Endothelin Antagonists Therapeutics Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. GSK Plc Company Profile and Main Business
Table 108. GSK Plc Recent Developments
List of Figure
Figure 1. Endothelin Antagonists Therapeutics Picture
Figure 2. By Revenue, Global Endothelin Antagonists Therapeutics Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Endothelin Antagonists Therapeutics Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Endothelin Antagonists Therapeutics Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Endothelin Antagonists Therapeutics Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Endothelin Antagonists Therapeutics Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Endothelin Antagonists Therapeutics Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Endothelin Antagonists Therapeutics Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Endothelin Antagonists Therapeutics Share of Global Market, 2018-2029
Figure 10. Global Endothelin Antagonists Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Endothelin Antagonists Therapeutics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Endothelin Antagonists Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Endothelin Antagonists Therapeutics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Endothelin Antagonists Therapeutics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Endothelin Antagonists Therapeutics Domestic VS Export, 2022
Figure 16. Global Endothelin Antagonists Therapeutics Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Endothelin Antagonists Therapeutics Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Endothelin Antagonists Therapeutics Production Market Share & Forecast by Region, 2018-2029
Figure 19. Endothelin Antagonists Therapeutics Industry Chain
Figure 20. Endothelin Antagonists Therapeutics Procurement Model
Figure 21. Endothelin Antagonists Therapeutics Sales Model
Figure 22. Endothelin Antagonists Therapeutics Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. Parenteral
Figure 25. By Type, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Endothelin Antagonists Therapeutics Revenue Market Share, 2018-2029
Figure 27. By Type, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Endothelin Antagonists Therapeutics Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Endothelin Antagonists Therapeutics Price, 2018-2029, (US$/Unit)
Figure 30. Cardiovascular Diseases
Figure 31. Scleroderma
Figure 32. Other
Figure 33. By Application, Global Endothelin Antagonists Therapeutics Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Endothelin Antagonists Therapeutics Revenue Market Share, 2018-2029
Figure 35. By Application, Global Endothelin Antagonists Therapeutics Sales Volume, 2018-2029, (K Units)
Figure 36. By Application, Global Endothelin Antagonists Therapeutics Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Endothelin Antagonists Therapeutics Price, 2018-2029, (US$/Unit)
Figure 38. By Region, Global Endothelin Antagonists Therapeutics Revenue Market Share, 2018-2029
Figure 39. By Region, Global Endothelin Antagonists Therapeutics Sales Volume Market Share, 2018-2029
Figure 40. North America Endothelin Antagonists Therapeutics Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Endothelin Antagonists
Research Methodology:
Endothelin Antagonists Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|